Coredio Receives FDA Breakthrough Device Designation for CPSE and Acceptance into the FDA TAP Program
FDA Breakthrough Device Designation Combining personalized calibration, wearables, and AI for proactive heart failure care. FDA BREAKTHROUGH DEVICE • TAP PILOT ACCEPTED Coredio Newsroom May 28, 2026 4 min to read Coredio Receives FDA Breakthrough Device Designation for CPSE™ and Acceptance into the FDA TAP Program A Software as a Medical Device platform built to […]